newsio aggregates and links to original sources. We do not own the original images or content. If you believe content infringes on intellectual property rights, contact us — it will be removed at first notice.

biotech / news / / The Boston Globe

Eli Lilly & Co. agrees to buy Kelonia Therapeutics for as much as $7 billion.

Eli Lilly is acquiring Kelonia Therapeutics for up to $7 billion.

KEY POINTS
COMPANIES
Read the full story on The Boston Globe →
Share X LinkedIn

Summarized by Newsio from The Boston Globe. How we summarize →